Coronavirus Update: US Considers Half Dose Of Moderna Vaccine To Maximize Coverage
UK And US Look To Increase Vaccination Rate
Operation Warp Speed leader wants to look at half dose of Moderna vaccine - but pledges that final decision will belong to the US FDA.
You may also be interested in...
Moderna is speculated to be in talks with Indian firms, including Wockhardt and a Tata group company, for manufacturing and/or marketing its COVID-19 vaccine. A deal in India could help the company meet its obligation to supply COVAX but Moderna is likely to choose its partner carefully.
Entering a new lockdown, the UK sees its plans to space out doses of the COVID-19 vaccines to 12 weeks as crucial to overcoming the pandemic.
The company’s announcement that it would supply at least 600 million doses of mRNA-1273 came as US vaccination rates have fallen far short of expectations.